Alimera Sciences (ALIM) Reports In-Line Q3 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. SPY
5. ANT
6. META
7. INTC
8. JBLU
9. BA
10. AAPL

Go back to Alimera Sciences (ALIM) Reports In-Line Q3 EPS

Alimera Sciences Reports Third Quarter 2015 Financial Results

November 5, 2015 4:19 PM EST

ATLANTA, Nov. 5, 2015 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced financial results for the third quarter ended September 30, 2015.

"ILUVIEN® continued to see growing demand in the U.S. during the quarter which has enabled us to achieve significant overall sales growth of 188% from the same period of 2014," said Dan Myers, Alimera president and chief executive officer. "As we had anticipated, the market opportunity in the U.S. is significant... More